Who knows how long patients with advanced gastric cancer can live? After gastrectomy, the surgical field will induce the growth of cancer cells and induce them to form clones with anti-chemotherapy properties. In the experimental model, it was found that the number of tumor cells was reduced by preoperative chemotherapy, thus inhibiting the production of this proliferation stimulating factor. In recent years, many approaches have been explored around adjuvant chemotherapy for gastric cancer. Mai et al. applied FAM or MTX to 24 patients before operation.

After FU chemotherapy, 50% of the patients had lymph node shrinkage, 8 1.

Cancer ascites disappeared completely in 5% patients, 68.

2% patients underwent total gastrectomy and extended lymph node dissection, and the average survival time after operation was 65438 04 months, while the control group only survived for 4 ~ 6 months without adjuvant chemotherapy. It is considered that for advanced gastric cancer, if adjuvant chemotherapy can effectively inhibit tumor tissue, the prognosis of patients can be improved.